Xu L - Search Results

1

A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.

Chen J, Landegger LD, Sun Y, Ren J, Maimon N, Wu L, Ng MR, Chen JW, Zhang N, Zhao Y, Gao X, Fujita T, Roberge S, Huang P, Jain RK, Plotkin SR, Stankovic KM, Xu L. Chen J, et al. Among authors: xu l. Nat Protoc. 2019 Feb;14(2):541-555. doi: 10.1038/s41596-018-0105-7. Nat Protoc. 2019. PMID: 30617350 Free PMC article.

2

Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF.

Xu L, Fukumura D, Jain RK. Xu L, et al. J Biol Chem. 2002 Mar 29;277(13):11368-74. doi: 10.1074/jbc.M108347200. Epub 2001 Dec 11. J Biol Chem. 2002. PMID: 11741977 Free article.

3

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

Izumi Y, Xu L, di Tomaso E, Fukumura D, Jain RK. Izumi Y, et al. Among authors: xu l. Nature. 2002 Mar 21;416(6878):279-80. doi: 10.1038/416279b. Nature. 2002. PMID: 11907566

4

Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis.

Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, Chatterjee K, Garkavtsev I, Jain RK. Fukumura D, et al. Among authors: xu l. Circ Res. 2003 Oct 31;93(9):e88-97. doi: 10.1161/01.RES.0000099243.20096.FA. Epub 2003 Oct 2. Circ Res. 2003. PMID: 14525808 Free PMC article.

5

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK. Garkavtsev I, et al. Among authors: xu l. Nature. 2004 Mar 18;428(6980):328-32. doi: 10.1038/nature02329. Nature. 2004. PMID: 15029197

6

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK. Winkler F, et al. Among authors: xu l. Cancer Cell. 2004 Dec;6(6):553-63. doi: 10.1016/j.ccr.2004.10.011. Cancer Cell. 2004. PMID: 15607960 Free article.

7

NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.

Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura D. Kashiwagi S, et al. Among authors: xu l. J Clin Invest. 2005 Jul;115(7):1816-27. doi: 10.1172/JCI24015. Epub 2005 Jun 9. J Clin Invest. 2005. PMID: 15951843 Free PMC article.

8

Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.

Xu L, Tong R, Cochran DM, Jain RK. Xu L, et al. Cancer Res. 2005 Jul 1;65(13):5711-9. doi: 10.1158/0008-5472.CAN-04-4313. Cancer Res. 2005. PMID: 15994946

9

Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis.

Hagendoorn J, Tong R, Fukumura D, Lin Q, Lobo J, Padera TP, Xu L, Kucherlapati R, Jain RK. Hagendoorn J, et al. Among authors: xu l. Cancer Res. 2006 Apr 1;66(7):3360-4. doi: 10.1158/0008-5472.CAN-05-2655. Cancer Res. 2006. PMID: 16585153

10

Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models.

Xu L, Cochran DM, Tong RT, Winkler F, Kashiwagi S, Jain RK, Fukumura D. Xu L, et al. Cancer Res. 2006 Apr 15;66(8):3971-7. doi: 10.1158/0008-5472.CAN-04-3085. Cancer Res. 2006. PMID: 16618713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,936 results

Search Page

Filters